Table: Fuji Pharmaceutical - 9-MTH group results

Fuji Pharma

09/08/2018 08:30

Aug 9 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Jun 30, 2018        Jun 30, 2017     Sep 30, 2018 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             27.87               26.02            38.14    
                 (+7.1 pct)          (+3.9 pct)       (+7.8 pct)  
  Operating          3.55                3.56             4.85    
                 (-0.4 pct)          (+24.8 pct)      (+12.4 pct) 
  Recurring          3.56                3.82             4.71    
                 (-6.9 pct)          (+49.3 pct)      (+1.8 pct)  
  Net                2.61                2.69             3.35    
                 (-3.0 pct)          (+61.4 pct)      (+1.3 pct)  
  EPS             87.10 yen           89.84 yen       111.76 yen  
  Ann Div                             48.00 yen                   
  -Q2 div         28.00 yen           23.00 yen                   
  -Q4 div                             25.00 yen        14.00 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T